| 标题 |
Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Shaodong Hong; Ting Zhou; Xue Hou; Xiangjiao Meng; Zhihuang Hu; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)